Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE

OBJECTIVE: We compared the physician-assessed diagnostic likelihood of SLE resulting from standard diagnosis laboratory testing (SDLT) to that resulting from multianalyte assay panel (MAP) with cell-bound complement activation products (MAP/CB-CAPs), which reports a two-tiered index test result havi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, Daniel J, Alexander, Roberta Vezza, O'Malley, Tyler, Khosroshahi, Arezou, Hojjati, Mehrnaz, Loupasakis, Konstantinos, Alper, Jeffrey, Sherrer, Yvonne, Fondal, Maria, Kataria, Rajesh, Powell, Tami, Ibarra, Claudia, Narain, Sonali, Massarotti, Elena, Weinstein, Arthur, Dervieux, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762037/
https://www.ncbi.nlm.nih.gov/pubmed/31592328
http://dx.doi.org/10.1136/lupus-2019-000349

Ejemplares similares

Ejemplares similares